Infectious Disease
UT Health San Antonio examines infectious diseases of regional and national significance, including hepatitis, HIV, multidrug resistant bacteria, clostridium difficile and MRSA infections.
Infectious disease expert Sunil Ahuja, M.D. earned the prestigious MERIT Award an honor bestowed on less than five percent of NIH-funded researchers.
Our research in antifungal therapies is nationally and internationally renowned.
Clinical trial participation is an invaluable way to contribute to the pursuit of new treatments for infectious diseases. Take action today...volunteer and play a role in finding a cure.
Find
UT Health San Antonio partners with the Vaccine Development Center of San Antonio which fosters research collaborations to promote excellence in vaccine development.
Additional Highlights
-
San Antonio researchers making hand sanitizer for the front line
Following the tradition of World War II’s Rosie the Riveter, compassionate scientists at UT Health San Antonio and The University of Texas at San Antonio are backfilling the front-lines pandemic effort by making hand sanitizer for UT Health care providers.
Read the full story in the Newsroom -
San Antonians with weak immune systems face challenges in pandemic
The San Antonio Partnership for Precision Therapeutics (SAPPT) has announced the funding of three projects that will accelerate treatments for COVID-19 using precision medicine principles.
Read the article at Health IT Analytics -
Researchers study antibodies against coronavirus
UT Health San Antonio is supporting multiple research projects in vaccine development. “We are working very fast to attack this problem because until we have a vaccine and a therapy, this virus represents a huge threat to humanity,” Dr. Hromas said.
Read the full story in the Newsroom -
On the hunt for a vaccine
As laboratories across the country rush to find answers for the novel coronavirus, UT Health San Antonio is bringing a unique combination of expertise to bear on the crisis. The goal is a precise and effective vaccine to prevent infection, said Robert Hromas, M.D., professor and dean of the university’s Long School of Medicine. The university is supporting multiple research projects in vaccine development.
Read the article in the Impact Magazine